Mayes Patrick A

Mayes Patrick A serves as the Executive Vice President and Chief Scientific Officer at Incyte Corporation, a leading biopharmaceutical company focused on innovative cancer therapies. His recent financial disclosures, covering the period from October 3, 2025, to July 7, 2026, primarily reflect sale activity related to Incyte Corporation (ticker: INCY). Over this timeframe, he reported a total of five disclosures, all linked to the healthcare sector, with his largest sale amounting to approximately $530.8K on December 12, 2025.